| van Gils MJ, Euler Z, Schweighardt B, Wrin T, Schuitemaker H. Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression. AIDS 2009; 23(18):2405-2414. abstract |
| Polonis VR, Schuitemaker H, Bunnik EM, Brown BK, Scarlatti G. Impact of host cell variation on the neutralization of HIV-1 in vitro. Curr Opin HIV AIDS 2009; 4(5):400-407. abstract |
| Rits MA. Cellular Factors Involved in HIV-1 Replication. University of Amsterdam, Amsterdam, June 23, 2009; |
| Navis M. Cellular immunity driving HIV-1 evolution. University of Amsterdam, Amsterdam, March 6, 2009; |
| van Manen D, Kootstra NA, Boeser-Nunnink B, Handulle MA, van't Wout AB, Schuitemaker H. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS 2009; 23(1):19-28. abstract |
| Wijbrandts CA, Remans PH, Klarenbeek PL, Wouters D, van den Bergh Weerman MA, Smeets TJ, Vervoordeldonk MJ, Baeten D, Tak PP. Analysis of apoptosis in peripheral blood and synovial tissue very early after initiation of infliximab treatment in rheumatoid arthritis patients. Arthritis Rheum 2008; 58(11):3330-3339. abstract |
| Steingrover R, Pogany K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy. AIDS 2008; 22(13):1583-1588. abstract |
| Scherrenburg J, Piriou ER, Nanlohy NM, van Baarle D. Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis. Clin Exp Immunol 2008; 153(2):231-239. abstract |
| Bunnik EM, Pisas L, van Nuenen AC, Schuitemaker H. Autologous Neutralizing Humoral Immunity and Evolution of the Viral Envelope in the Course of Subtype B Human Immunodeficiency Virus Type 1 Infection. J Virol 2008; 82(16):7932-7941. abstract |
| Diehl SA, Schmidlin H, Nagasawa M, van Haren SD, Kwakkenbos MJ, Yasuda E, Beaumont T, Scheeren FA, Spits H. STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J Immunol 2008; 180(7):4805-4815. abstract |
| van 't Wout AB, Schuitemaker H, Kootstra NA. Isolation and propagation of HIV-1 on peripheral blood mononuclear cells. Nat Protoc 2008; 3(3):363-370. abstract |
| Blaak H, Boers PH, van der Ende ME, Schuitemaker H, Osterhaus AD. CCR5-restricted HIV type 2 variants from long-term aviremic individuals are less sensitive to inhibition by beta-chemokines than low pathogenic HIV type 1 variants. AIDS Res Hum Retroviruses 2008; 24(3):473-484. abstract |
| Navis M, Schellens IM, van Swieten P, Borghans JA, Miedema F, Kootstra NA, van Baarle D, Schuitemaker H. A Nonprogressive Clinical Course in HIV-Infected Individuals Expressing Human Leukocyte Antigen B57/5801 Is Associated with Preserved CD8(+) T Lymphocyte Responsiveness to the HW9 Epitope in Nef. J Infect Dis 2008; 197(6):871-879. abstract |
| van Manen D, Rits MA, Beugeling C, van Dort K, Schuitemaker H, Kootstra NA. The Effect of Trim5 Polymorphisms on the Clinical Course of HIV-1 Infection. PLoS Pathog 2008; 4(2):e18. abstract |
| Piriou E, van Dort K, Otto S, van Oers MH, van Baarle D. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection. Clin Infect Dis 2008; 46(2):313-316. abstract |
| Terpstra FG, 't Wout AB, Schuitemaker H, van Engelenburg FA, Dekkers DW, Verhaar R, de Korte D, Verhoeven AJ. Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates. Transfusion 2008; 48(2):304-313. abstract |
| Vermeulen JN, Prins JM, Bunnik E, Hack CE, Jurriaans S, Miedema F, Lange JM, Schuitemaker H. Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals. AIDS Res Hum Retroviruses 2007; 23(11):1348-1353. abstract |
| van Till JW, Modderman PW, de Boer M, Hart MH, Beld MG, Boermeester MA. Mannose-binding lectin deficiency facilitates abdominal yeast infection in patients with secondary peritonitis. Clin Vaccine Immunol 2008; 15(1):65-70. abstract |
| Corcoran A, Kerr S, Elliott G, Koppelman M, Doyle S. Improved detection of acute parvovirus B19 infection by immunoglobulin M EIA in combination with a novel antigen EIA. Vox Sang 2007; 93(3):216-222. abstract |
| Kootstra NA, Navis M, Beugeling C, van Dort KA, Schuitemaker H. The presence of the Trim5alpha escape mutation H87Q in the capsid of late stage HIV-1 variants is preceded by a prolonged asymptomatic infection phase. AIDS 2007; 21(15):2015-2023. abstract |
| Navis M, Schellens I, van Baarle D, Borghans J, van Swieten P, Miedema F, Kootstra N, Schuitemaker H. Viral Replication Capacity as a Correlate of HLA B57/B5801-Associated Nonprogressive HIV-1 Infection. J Immunol 2007; 179(5):3133-3143. abstract |
| Bronke C, Jansen CA, Westerlaken GH, De Cuyper IM, Miedema F, Tesselaar K, van Baarle D. Shift of CMV-specific CD4+ T-cells to the highly differentiated CD45RO-. Clin Immunol 2007; 124(2):190-199. abstract |
| Choudhary SK, Vrisekoop N, Jansen CA, Otto SA, Schuitemaker H, Miedema F, Camerini D. Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol 2007; 81(16):8838-8842. abstract |
| Zaaijer HL, van Hemert FJ, Koppelman MH, Lukashov VV. Independent evolution of overlapping polymerase and surface protein genes of hepatitis B virus. J Gen Virol 2007; 88(Pt 8):2137-2143. abstract |
| Terpstra FG, van den Blink AE, Bos LM, Boots AG, Brinkhuis FH, Gijsen E, van Remmerden Y, Schuitemaker H, 't Wout AB. Resistance of surface-dried virus to common disinfection procedures. J Hosp Infec 2007; 66:332-338. abstract |
| Terpstra F. Viral safety of blood and plasma products. University of Amsterdam, Amsterdam, June 19, 2007; |
| Quakkelaar ED, van Alphen FP, Boeser-Nunnink BD, van Nuenen AC, Pantophlet R, Schuitemaker H. Susceptibility of Recently Transmitted Subtype B HIV-1 Variants to Broadly Neutralizing Antibodies. J Virol 2007; 81(16):8533-8542. abstract |
| Tepaske R, te Velthuis H, Oudemans-van Straaten HM, Bossuyt PM, Schultz MJ, Eijsman L, Vroom M. Glycine Does Not Add to the Beneficial Effects of Perioperative Oral Immune-Enhancing Nutrition Supplements in High-Risk Cardiac Surgery Patients. JPEN J Parenter Enteral Nutr 2007; 31(3):173-180. abstract |
| Tsegaye A, Ran L, Wolday D, Petros B, Dorigo W, Piriou E, Messele T, Sanders E, Tilahun T, Eshetu D, Schuitemaker H, Coutinho RA, Miedema F, Borghans J, van Baarle D. HIV-1 Subtype C Gag-Specific T-Cell Responses in Relation to Human Leukocyte Antigens in a Diverse Population of HIV-Infected Ethiopians. J Acquir Immune Defic Syndr 2007; 45(4):389-400. abstract |
| Quakkelaar ED. Antibody neutralization of HIV-1. University of Amsterdam, Amsterdam, March 23, 2007; |
| Burnouf T, Terpstra F, Habib G, Seddik S. Assessment of viral inactivation during pH 3.3 pepsin digestion and caprylic acid treatment of antivenoms. Biologicals 2007; 35(4):329-334. abstract |
| Quakkelaar ED, Beaumont T, van Nuenen AC, van Alphen FP, Boeser-Nunnink BD, van 't Wout AB, Schuitemaker H. T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates. Virology 2007; 359(1):92-104. abstract |
| Terpstra FG, Rechtman DJ, Lee ML, Hoeij KV, Berg H, Engelenberg FA, Wout AB. Antimicrobial and Antiviral Effect of High-Temperature Short-Time (HTST) Pasteurization Applied to Human Milk. Breastfeed Med 2007; 2(1):27-33. abstract |
| Rits MA, van Dort KA, Munk C, Meijer AB, Kootstra NA. Efficient Transduction of Simian Cells by HIV-1-based Lentiviral Vectors that Contain Mutations in the Capsid Protein. Mol Ther 2007; 15(5):930-937. abstract |
| Vrisekoop N. T-cell dynamics in healthy and HIV-infected individuals. University of Utrecht, Utrecht, March 1, 2007; |
| Tsegaye A, Ran L, Wolday D, Petros B, Nanlohy NM, Meles H, Girma M, Hailu E, Borghans J, Miedema F, Baarle DV. Stable pattern of HIV-1 subtype C Gag-specific T-cell responses coincides with slow rate of CD4 T-cell decline in HIV-infected Ethiopians. AIDS 2007; 21(3):369-372. abstract |
| Bunnik EM, Quakkelaar ED, van Nuenen AC, Boeser-Nunnink B, Schuitemaker H. Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient. J Virol 2007; 81(2):525-531. abstract |
| Sankatsing SU, Cornelissen M, Kloosterboer N, Crommentuyn KM, Bosch TM, Mul FP, Jurriaans S, Huitema AD, Beijnen JH, Lange JM, Prins JM, Schuitemaker H. Antiviral Activity of HIV Type 1 Protease Inhibitors Nelfinavir and Indinavir in Vivo Is Not Influenced by P-Glycoprotein Activity on CD4(+) T Cells. AIDS Res Hum Retroviruses 2007; 23(1):19-27. abstract |
| Bekker V, Scherpbier H, Beld M, Piriou E, Breda A, Lange J, Leth F, Jurriaans S, Alders S, Dillen PW, Baarle D, Kuijpers T. Epstein-Barr Virus Infects B and Non-B Lymphocytes in HIV-1-Infected Children and Adolescents. J Infect Dis 2006; 194(9):1323-1330. abstract |
| Bunnik EM, Quakkelaar ED, van Nuenen AC, Boeser-Nunnink B, Schuitemaker H. Increased neutralization sensitivity of recently emerged CXCR4-using HIV-1 as compared to co-existing CCR5-using variants from the same patient. J Virol 2006; 81(2):525-531. abstract |
| Terpstra FG, Kleijn M, Koenderman AH, Over J, van Engelenburg FA, Schuitemaker H, van't Wout AB. Viral safety of C1-inhibitor NF. Biologicals 2007; 35:173-181. abstract |
| Quakkelaar ED, Beaumont T, van Nuenen AC, van Alphen FP, Boeser-Nunnink BD, van 't Wout AB, Schuitemaker H. T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates. Virology 2006; 359:92-104. abstract |
| van Thienen JV, Fledderus JO, Dekker RJ, Rohlena J, van Ijzendoorn GA, Kootstra NA, Pannekoek H, Horrevoets AJ. Shear stress sustains atheroprotective endothelial KLF2 expression more potently than statins through mRNA stabilization. Cardiovasc Res 2006; 72(2):231-240. abstract |
| Koppelman MH. Viral safety of blood donations : Molecular detection of blood transmittable viruses. University of Amsterdam, Amsterdam, June 28, 2006; |
| Blaak H, van der Ende ME, Boers PH, Schuitemaker H, Osterhaus AD. In vitro replication capacity of HIV-2 variants from long-term aviremic individuals. Virology 2006; 353:144-154. abstract |
| Krol A, Lensen R, Veenstra J, Prins M, Schuitemaker H, Coutinho RA. Impact of CCR5 Delta32/+ Deletion on Herpes Zoster Among HIV-1-Infected Homosexual Men. Eur J Epidemiol 2006; 21(6):469-473. abstract |
| Jansen CA, Piriou E, De Cuyper IM, van Dort K, Lange JM, Miedema F, van Baarle D. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity. Antivir Ther 2006; 11(1):105-116. abstract |
| Koppelman MH, Sjerps MS, de Waal M, Reesink HW, Cuypers HT. No evidence of West Nile virus infection in Dutch blood donors. Vox Sang 2006; 90(3):166-169. abstract |
| Piriou ER, van Dort K, Weel JF, Bemelman FJ, Gamadia LE, van Oers MH, van Baarle D. Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient. Clin Immunol 2006; 119(1):16-20. abstract |
| Jansen CA, De Cuyper IM, Hooibrink B, van der Bij AK, van Baarle D, Miedema F. Prognostic value of HIV-1 Gag-specific CD4+ T-cell responses for progression to AIDS analyzed in a prospective cohort study. Blood 2006; 107(4):1427-1433. abstract |
| Geels MJ, Jansen CA, Baan E, De Cuyper IM, van Schijndel GJ, Schuitemaker H, Goudsmit J, Pollakis G, Miedema F, Paxton WA, van Baarle D. CTL escape and increased viremia irrespective of HIV-specific CD4(+) T-helper responses in two HIV-infected individuals. Virology 2006; 345(1):209-219. abstract |
| Jansen CA, van Baarle D, Miedema F. HIV-specific CD4(+) T cells and viremia: who′s in control?. Trends Immunol 2006; 27(3):119-124. abstract |
| Terpstra FG, Parkkinen J, Tölö H, Koenderman AH, Ter Hart HG, von Bonsdorff L, Törmä E, van Engelenburg FA. Viral safety of Nanogam(R), a new 15 nm-filtered liquid immunoglobulin product. Vox Sang 2006; 90(1):21-32. abstract |
| Piriou ER, van Dort K, Weel JF, Bemelman FJ, Gamadia LE, van Oers MH, van Baarle D. Detailed kinetics of EBV-specific CD4(+) and CD8(+) T cells during primary EBV infection in a kidney transplant patient. Clin Immunol 2005; 119:16-20. abstract |
| Vrisekoop N, Sankatsing SU, Jansen CA, Roos MT, Otto SA, Schuitemaker H, Lange JM, Prins JM, Miedema F. Short Communication: No Detrimental Immunological Effects of Mycophenolate Mofetil and HAART in Treatment-Naive Acute and Chronic HIV-1-Infected Patients. AIDS Res Hum Retroviruses 2005; 21(12):991-996. abstract |
| Hailu A, van Baarle D, Knol GJ, Berhe N, Miedema F, Kager PA. T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani. Clin Immunol 2005; 117(2):182-191. abstract |
| Koning FA, Otto SA, Hazenberg MD, Dekker L, Prins M, Miedema F, Schuitemaker H. Low-Level CD4+ T Cell Activation Is Associated with Low Susceptibility to HIV-1 Infection. J Immunol 2005; 175(9):6117-6122. abstract |
| Jansen CA, De Cuyper IM, Hooibrink B, van der Bij AK, van Baarle D, Miedema F. Prognostic value of HIV-1 Gag-specific CD4+ T-cell responses for progression to AIDS analysed in a prospective cohort study. Blood 2005; 107(4):1427-1433. abstract |
| Bronke C, Palmer NM, Westerlaken GH, Toebes M, van Schijndel GM, Purwaha V, van Meijgaarden KE, Schumacher TN, van Baarle D, Tesselaar K, Geluk A. Direct Ex Vivo Detection of HLA-DR3-Restricted Cytomegalovirus- and Mycobacterium tuberculosis-Specific CD4(+) T Cells. Hum Immunol 2005; 66(9):950-961. abstract |
| Koning FA, Koevoets C, van der Vorst TJ, Schuitemaker H. Sensitivity of primary R5 HTV-1 to inhibition by RANTES correlates with sensitivity to small-molecule R5 inhibitors. Antivir Ther 2005; 10(2):231-237. abstract |
| Kootstra NA, Schuitemaker H. Determination of cell tropism of HIV-1. Methods in Molecular Biology ; vol. 304 : Human Retrovirus Protocols : Virology and Molecular Biology 2005; 304(24):317-325. abstract |
| Mekonnen Y, Geskus RB, Hendriks JC, Messele T, Borghans J, Miedema F, Wolday D, Coutinho RA, Dukers NH. Low CD4 T Cell Counts before HIV-1 Seroconversion Do Not Affect Disease Progression in Ethiopian Factory Workers. J Infect Dis 2005; 192(5):739-748. abstract |
| Schuitemaker H, Kootstra NA. Determination of co-receptor usage of HIV-1. Methods in Molecular Biology ; vol. 304 : Human Retrovirus Protocols : Virology and Molecular Biology 2005; 304(25):327-332. abstract |
| Schuitemaker H, Kootstra NA. Isolation, propagation, and titration of human immunodeficiency virus type 1 from peripheral blood of infected individuals. 2005; 304(2):17-24. abstract |
| Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations. Transfusion 2005; 45(8):1258-1266. abstract |
| Piriou E, Jansen CA, Dort K, de Cuyper I, Nanlohy NM, Lange JM, van Oers MH, Miedema F, van Baarle D. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy. J Immunol 2005; 175(3):2010-2017. abstract |
| Jansen CA, De Cuyper IM, Steingrover R, Jurriaans S, Sankatsing SU, Prins JM, Lange JM, van Baarle D, Miedema F. Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions. AIDS 2005; 19(11):1145-1154. abstract |
| Piriou E, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D. Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin Lymphoma. Blood 2005; 106(9):3166-3174. abstract |
| Bekker V, Bronke C, Scherpbier HJ, Weel JF, Jurriaans S, Wertheim-van Dillen PM, Leth FV, Lange JM, Tesselaar K, Baarle DV, Kuijpers TW. Cytomegalovirus rather than HIV triggers the outgrowth of effector CD8+CD45RA+. AIDS 2005; 19(10):1025-1034. abstract |
| Geskus RB, Meyer L, Hubert JB, Schuitemaker H, Berkhout B, Rouzioux C, Theodorou ID, Delfraissy JF, Prins M, Coutinho RA. Causal Pathways of the Effects of Age and the CCR5-Delta32, CCR2-64I, and SDF-1 3′A Alleles on AIDS Development. J Acquir Immune Defic Syndr 2005; 39(3):321-326. abstract |
| Wolday D, Tegbaru B, Kassu A, Messele T, Coutinho R, van Baarle D, Miedema F. Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients. J Acquir Immune Defic Syndr 2005; 39(3):265-271. abstract |
| Kloosterboer N, Groeneveld PH, Jansen CA, van der Vorst TJ, Koning F, Winkel CN, Duits AJ, Miedema F, van Baarle D, van Rij RP, Brinkman K, Schuitemaker H. Natural controlled HIV infection: Preserved HIV-specific immunity despite undetectable replication competent virus. Virology 2005; 339(1):70-80. abstract |
| van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, Lange JM, Coutinho RA, Schuitemaker H. Reply to George and to Stapleton et al. J Infect Dis 2005; 191(12):2158-2160. abstract |
| Koning FA, van der Vorst TJ, Schuitemaker H. Low levels of human immunodeficiency virus type 1 DNA in high-risk seronegative men. J Virol 2005; 79(10):6551-6553. abstract |
| Bronke C. Cytomegalovirus-specific T-cell dynamics in HIV infection. University of Amsterdam, Amsterdam, March 24, 2005; |
| Jansen CA. Analysis of HIV-specific T-cell immunity in AIDS-pathogenesis. University of Utrecht, Utrecht, May 13th. 2005; |
| Bronke C, Palmer NM, Jansen CA, Westerlaken GH, Polstra AM, Reiss P, Bakker M, Miedema F, Tesselaar K, van Baarle D. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease. J Infect Dis 2005; 191(6):873-880. abstract |
| Bronke C, Westerlaken GH, Miedema F, Tesselaar K, van Baarle D. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8(+) T-cells. Immunol Lett 2005; 97(2):215-224. abstract |
| Abuye C, Tsegaye A, West CE, Versloot P, Sanders EJ, Wolday D, Hamann D, de Wit TF, Fontanet AL. Determinants of CD4 counts among HIV-negative Ethiopians: role of body mass index, gender, cigarette smoking, khat (Catha Edulis) chewing, and possibly altitude?. J Clin Immunol 2005; 25(2):127-133. abstract |
| Piriou ER. Viro-Immunology of EBV - HIV co-infection. University of Amsterdam, Amsterdam, March 31, 2005; |
| van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, Lange JM, Coutinho RA, Schuitemaker H. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J Infect Dis 2005; 191(5):678-685. abstract |
| Piriou ER, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D. Novel method for detection of virus-specific CD4(+) T cells indicates a decreased EBV-specific CD4(+) T cell response in untreated HIV-infected subjects. Eur J Immunol 2005; 35(3):796-805. abstract |
| van Baarle D, Tsegaye A, Miedema F, Akbar A. Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system. Immunol Lett 2005; 97(1):19-29. abstract |
| Blaak H, Boers PH, Gruters RA, Schuitemaker H, van der Ende ME, Osterhaus AD. CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia. J Virol 2005; 79(3):1686-1700. abstract |
| Kivela PS, Krol A, Salminen MO, Geskus RB, Suni JI, Anttila VJ, Liitsola K, Zetterberg V, Miedema F, Berkhout B, Coutinho RA, Ristola MA. High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland. Scand J Infect Dis 2005; 37(4):276-283. abstract |
| Choudhary SK, Choudhary NR, Kimbrell KC, Colasanti J, Ziogas A, Kwa D, Schuitemaker H, Camerini D. R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression. J Virol 2005; 79(1):458-471. abstract |
| Jansen CA, Kostense S, Vandenberghe K, Nanlohy NM, De Cuyper IM, Piriou E, Manting EH, Miedema F, van Baarle D. High responsiveness of HLA-B57-restricted Gag-specific CD8(+) T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection. Eur J Immunol 2005; 35(1):150-158. abstract |
| Jansen CA, Piriou E, Bronke C, Vingerhoed J, Kostense S, van Baarle D, Miedema F. Characterization of virus-specific CD8(+) effector T cells in the course of HIV-1 infection: longitudinal analyses in slow and rapid progressors. Clin Immunol 2004; 113(3):299-309. abstract |
| Zaaijer HL, Koppelman MH, Farrington CP. Parvovirus B19 viraemia in Dutch blood donors. Epidemiol Infect 2004; 132(6):1161-1166. abstract |
| Koning FA. Determinants of host HIV-1 susceptibility and R5 HIV-1 evolution [Thesis]. University of Amsterdam, Amsterdam, November 26, 2004 2004; |
| Sankatsing SU, Jurriaans S, van Swieten P, van Leth F, Cornelissen M, Miedema F, Lange JM, Schuitemaker H, Prins JM. Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients. AIDS 2004; 18(14):1925-1931. abstract |
| van Asten L, Danisman F, Otto SA, Borghans JA, Hazenberg MD, Coutinho RA, Prins M, Miedema F. Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection. AIDS 2004; 18(14):1885-1893. abstract |
| Hazenberg MD, Otto SA, van Rossum AM, Scherpbier HJ, de Groot R, Kuijpers TW, Lange JM, Hamann D, de Boer RJ, Borghans JA, Miedema F. Establishment of the CD4+ T cell pool in healthy and untreated HIV-1 infected children. Blood 2004; 104(12):3513-3519. abstract |
| Li J, de Korte D, Woolum MD, Ruane PH, Keil SD, Lockerbie O, McLean R, Goodrich RP. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products. Vox Sang 2004; 87(2):82-90. abstract |
| Trannoy LL, Lagerberg JW, Dubbelman TM, Schuitmaker HJ, Brand A. Positively charged porphyrins: a new series of photosensitizers for sterilization of RBCs. Transfusion 2004; 44(8):1186-1196. abstract |
| Nobile M, Correa R, Borghans JA, D'Agostino C, Schneider P, de Boer RJ, Pantaleo G. De novo T-cell generation in patients at different ages and stages of HIV-1 disease. Blood 2004; 104(2):470-477. abstract |
| Beaumont T, Quakkelaar E, van Nuenen A, Pantophlet R, Schuitemaker H. Increased sensitivity to CD4 binding site-directed neutralization following in vitro propagation on primary lymphocytes of a neutralization-resistant human immunodeficiency virus IIIB strain isolated from an accidentally infected laboratory worker. J Virol 2004; 78(11):5651-5657. abstract |
| Minor P, Newham J, Jones N, Bergeron C, Gregori L, Asher D, van Engelenburg F, Stroebel T, Vey M, Barnard G, Head M. Standards for the assay of Creutzfeldt-Jakob disease specimens. J Gen Virol 2004; 85(Pt 6):1777-1784. abstract |
| Piriou ER, van Dort K, Nanlohy NM, Miedema F, van Oers MH, van Baarle D. Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma. J Immunol 2004; 172(11):6931-6937. abstract |
| Koning FA, Jansen CA, Dekker J, Kaslow RA, Dukers N, van Baarle D, Prins M, Schuitemaker H. Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behaviour. AIDS 2004; 18(8):1117-1126. abstract |
| Koppelman MH, Zaaijer HL. Diversity and origin of hepatitis B virus in Dutch blood donors. J Med Virol 2004; 73(1):29-32. abstract |
| Loos BG, Roos MT, Schellekens PT, van der Velden U, Miedema F. Lymphocyte numbers and function in relation to periodontitis and smoking. J Periodontol 2004; 75(4):557-564. abstract |
| de Korte D, Verhoeven AJ. Quality determinants of erythrocyte destined for transfusion. Cell Mol Biol (Noisy-le-Grand) 2004; 50(2):187-195. abstract |
| Pollakis G, Abebe A, Kliphuis A, Chalaby MI, Bakker M, Mengistu Y, Brouwer M, Goudsmit J, Schuitemaker H, Paxton WA. Phenotypic and genotypic comparisons of CCR5- and CXCR4-Tropic human immunodeficiency virus type 1 biological clones isolated from subtype c-infected individuals. J Virol 2004; 78(6):2841-2852. abstract |
| Stalmeijer EH, van Rij RP, Boeser-Nunnink B, Visser JA, Naarding MA, Schols D, Schuitemaker H. In vivo evolution of X4 human immunodeficiency virus type 1 variants in the natural course of infection coincides with decreasing sensitivity to CXCR4 antagonists. J Virol 2004; 78(6):2722-2728. abstract |
| Boon AC, de Mutsert G, van Baarle D, Smith DJ, Lapedes AS, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF. Recognition of homo- and heterosubtypic variants of influenza a viruses by human CD8(+) T lymphocytes. J Immunol 2004; 172(4):2453-2460. abstract |
| Tsegaye A. T cell dynamics and HIV specific CTL responses in Ethiopians. University of Amsterdam, Amsterdam, December 15, 2004; |
| Koppelman MH, Cuypers HT, Emrich T, Zaaijer HL. Quantitative real-time detection of parvovirus B19 DNA in plasma. Transfusion 2004; 44(1):97-103. abstract |
| Geels MJ, Cornelissen M, Schuitemaker H, Anderson K, Kwa D, Maas J, Dekker JT, Baan E, Zorgdrager F, van den Burg R, van Beelen M, Lukashov VV, Fu TM, Paxton WA, van der Hoek L, Dubey SA, Shiver JW, Goudsmit J. Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual. J Virol 2003; 77(23):12430-12440. abstract |
| Tsegaye A, Wolday D, Otto S, Petros B, Assefa T, Alebachew T, Hailu E, Adugna F, Measho W, Dorigo W, Fontanet AL, van Baarle D, Miedema F. Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians. Clin Immunol 2003; 109(3):338-346. abstract |
| Mulherin SA, O'Brien TR, Ioannidis JPA, Goedert JJ, Buchbinder SP, Coutinho RA, Jamieson BD, Meyer L, Michael NL, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Theodorou ID, Vlahov D, Rosenberg PS. Effects of CCR5-Delta 32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS 2003; 17(3):377-387. abstract |
| Koning FA, Kwa D, Boeser-Nunnink B, Dekker J, Vingerhoed J, Hiemstra H, Schuitemaker H. Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection. J Infect Dis 2003; 188(6):864-872. abstract |
| van Rij RP, Worobey M, Visser JA, Schuitemaker H. Evolution of R5 and X4 human immunodeficiency virus type 1 gag sequences in vivo: evidence for recombination. Virology 2003; 314(1):451-459. abstract |
| Hazenberg MD, Otto SA, van Benthem BHB, Roos MTL, Coutinho RA, Lange JMA, Hamann D, Prins M, Miedema F. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003; 17(13):1881-1888. abstract |
| Hazenberg MD, Otto SA, Hamann D, Roos MTL, Schuitemaker H, de Boer RJ, Miedema F. Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation. AIDS 2003; 17(10):1419-1424. abstract |
| Meij P, van Esser JW, Niesters HG, van Baarle D, Miedema F, Blake N, Rickinson AB, Leiner I, Pamer E, Lowenberg B, Cornelissen JJ, Gratama JW. Impaired recovery of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood 2003; 101(11):4290-4297. abstract |
| Borghans JA, Beltman JB, de Boer RJ. MHC polymorphism under host-pathogen coevolution. Immunogenetics 2004; 55(11):732-739. abstract |
| Kwa D, van Rij RP, Boeser-Nunnink B, Vingerhoed J, Schuitemaker H. Association between an interleukin-4 promoter polymorphism and the acquisition of CXCR4 using HIV-1 variants. AIDS 2003; 17(7):981-985. abstract |
| Kwa D, Vingerhoed J, Boeser-Nunnink B, Schuitemaker H. Increased in vitro cytopathicity of CC chemokine receptor 5-restricted human immunodeficiency virus type 1 primary isolates correlates with a progressive clinical course of infection. J Infect Dis 2003; 187(9):1397-1403. abstract |
| van Rij RP, Hazenberg MD, van Benthem BH, Otto SA, Prins M, Miedema F, Schuitemaker H. Early Viral Load and CD4(+) T Cell Count, But Not Percentage of CCR5(+) or CXCR4(+) CD4(+) T Cells, Are Associated with R5-to-X4 HIV Type 1 Virus Evolution. AIDS Res Hum Retroviruses 2003; 19(5):389-398. abstract |
| Geskus RB, Miedema F, Goudsmit J, Reiss P, Schuitemaker H, Coutinho RA. Prediction of residual time to AIDS and death based on markers and cofactors. J Acquir Immune Defic Syndr 2003; 32(5):514-521. abstract |
| Arens R. Balancing effector lymphocyte formation via CD27-CD70 interactions. University of Amsterdam, Amsterdam, November 25, 2003; |
| Kassu A, Tsegaye A, Wolday D, Petros B, Aklilu M, Sanders EJ, Fontanet AL, van Baarle D, Hamann D, de Wit TF. Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clin Exp Immunol 2003; 132(1):113-119. abstract |
| Sankatsing SU, van Praag RM, van Rij RP, Rientsma R, Jurriaans S, Lange JM, Prins JM, Schuitemaker H. Dynamics of the pool of infected resting CD4 HLA-DR¯ T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection. Antivir Ther 2003; 8(2):137-142. abstract |
| Kwa D, Boeser-Nunnink B, Schuitemaker H. Lack of evidence for an association between a polymorphism in CX3CR1 and the clinical course of HIV infection or virus phenotype evolution. AIDS 2003; 17(5):759-761. abstract |
| Bogaards JA, Weverling GJ, Geskus RB, Miedema F, Lange JM, Bossuyt PM, Goudsmit J. Low versus high CD4 cell count as starting point for introduction of antiretroviral treatment in resource-poor settings: a scenario-based analysis. Antivir Ther 2003; 8(1):43-50. abstract |
| Hazenberg MD, Borghans JAM, de Boer RJ, Miedema F. Thymic output: a bad TREC record. Nat Immunol 2003; 4(2):97-99. abstract |
| Fraaij PL, van Rossum AM, Wolthers KC, Vossen AC, Jeucken YM, Kuijpers JH, van Lochem EG, Roos MT, de Groot R, Hartwig NG. Initation of highly active antiretroviral therapy leads to an HIV-specific immune response in a seronegative infant. AIDS 2003; 17(1):138-140. abstract |
| Tesselaar K, Arens R, van Schijndel GM, Baars PA, van der Valk MA, Borst J, van Oers MH, van Lier RA. Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nat Immunol 2003; 4(1):49-54. abstract |
| Tesselaar K, Xiao Y, Arens R, van Schijndel GM, Schuurhuis DH, Mebius RE, Borst J, van Lier RA. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J Immunol 2003; 170(1):33-40. abstract |
| van Baarle D, Kostense S, van Oers MH, Hamann D, Miedema F. Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue. Trends Immunol 2002; 23(12):586-591. abstract |
| Cohen Stuart J, Hamann D, Borleffs J, Roos M, Miedema F, Boucher C, de Boer R. Reconstitution of naive T cells during antiretroviral treatment of HIV-infected adults is dependent on age. AIDS 2002; 16(17):2263-2266. abstract |
| Bolscher JGM, Nazmi K, Ran LJ, van Engelenburg FAC, Schuitemaker H, Veerman ECI, Amerongen AVM. Inhibition of HIV-1IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva. Eur J Oral Sci 2002; 110(2):149-156. abstract |
| Davenport MP, Zaunders JJ, Hazenberg MD, Schuitemaker H, van Rij RP. Cell turnover and cell tropism in HIV-1 infection. Trends in Microbiology 2002; 10(6):275-278. abstract |
| Feinberg MB, McCune JM, Miedema F, Moore JP, Schuitemaker H. HIV tropism and CD4(+) T-cell depletion. Nat Med 2002; 8(6):537-537. abstract |
| Goudsmit J, Bogaards JA, Jurriaans S, Schuitemaker H, Lange JMA, Coutinho RA, Weverling GJ. Naturally HIV-1 seroconverters with lowest viral load have best prognosis, but in time lose control of viraemia. AIDS 2002; 16(5):791-793. abstract |
| Killestein J, Hintzen RQ, Uitdehaag BMJ, Baars PA, Roos MT, van Lier RAW, Polman CH. Baseline T cell reactivity in multiple sclerosis is correlated to efficacy of interferon-beta. J Neuroimmunol 2002; 133(1-2):217-224. abstract |
| Killestein J, Meilof JF, Ader HJ, Uitdehaag BMJ, Barkhof F, van Lier RAW, Polman CH. Seasonal variation in immune measurements and MRI markers of disease activity in MS. Neurology 2002; 58(7):1077-1080. abstract |
| Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, van Baarle D, Kostense S, Miedema F, McLaughlin M, Ehler L, Metcalf J, Liu S, Connors M. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002; 3(11):1061-1068. abstract |
| van der Vliet HJJ, von Blomberg BME, Hazenberg MD, Nishi N, Otto SA, van Benthem BH, Prins M, Claessen FA, van den Eertwegh AJM, Giaccone G, Miedema F, Scheper RJ, Pinedo HM. Selective decrease in circulating V alpha 24(+)V beta 11(+) NKT cells during HIV type 1 infection. J Immunol 2002; 168(3):1490-1495. abstract |
| Wit FWNM, van Rij RP, Weverling GJ, Lange JMA, Schuitemaker H. CC chemokine receptor 5 Delta 32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients. J Infect Dis 2002; 186(12):1726-1732. abstract |
| van Baarle D, Kostense S, Hovenkamp E, Ogg G, Nanlohy N, Callan MF, Dukers NH, McMichael AJ, van Oers MH, Miedema F. Lack of Epstein-Barr virus-and HIV specific CD27-CD8+T cells is associated with progression to viral disease in HIV infection. AIDS 2002; 16(15):2001-2011. abstract |
| van Rij RP, Schuitemaker H. Host Genetic Factors in the Clinical Course of HIV-1 Infection: Chemokines and Chemokine Receptors. Community Genet 2002; 5(2):88-101. abstract |
| van Baarle D, Wolthers KC, Hovenkamp E, Niesters HG, Osterhaus AD, Miedema F, van Oers MH. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. J Infect Dis 2002; 186(3):405-409. abstract |
| Maas J, Termorshuizen F, Geskus RB, Goettsch W, Coutinho RA, Miedema F, van Loveren H. Amsterdam Cohort Study on HIV and AIDS: impact of exposure to UVR as estimated by means of a 2-year retrospective questionnaire on immune parameters in HIV positive males. Int J Hyg Environ Health 2002; 205(5):373-377. abstract |
| Termorshuizen F, Geskus RB, Roos MT, Coutinho RA, van Loveren H. Seasonal influences on immunological parameters in HIV-infected homosexual men: searching for the immunomodulating effects of sunlight. Int J Hyg Environ Health 2002; 205(5):379-384. abstract |
| Hazenberg MD, Otto SA, Wit FW, Lange JM, Hamann D, Miedema F. Discordant responses during antiretroviral therapy: role of immune activation and T cell redistribution rather than true CD4 T cell loss. AIDS 2002; 16(9):1287-1289. abstract |
| van Engelenburg FA, Terpstra FG, Schuitemaker H, Moorer WR. The virucidal spectrum of a high concentration alcohol mixture. J Hosp Infect 2002; 51(2):121-125. abstract |
| Lindenburg CE, Stolte I, Langendam MW, Miedema F, Williams IG, Colebunders R, Weber JN, Fisher M, Coutinho RA. Long-term follow-up: no effect of therapeutic vaccination with HIV-1 p17/p24:Ty virus-like particles on HIV-1 disease progression. Vaccine 2002; 20(17-18):2343-2347. abstract |
| Hazenberg MD, Otto SA, de Pauw ES, Roelofs H, Fibbe WE, Hamann D, Miedema F. T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood 2002; 99(9):3449-3453. abstract |
| Kostense S, Otto SA, Knol GJ, Manting EH, Nanlohy NM, Jansen C, Lange JM, van Oers MH, Miedema F, van Baarle D. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells. Eur J Immunol 2002; 32(4):1080-1089. abstract |
| Kostense S, van den Berghe K, Joling J, van Baarle D, Nanlohy N, Manting E, Miedema F. Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS. Blood 2002; 99(7):2505-2511. abstract |
| Labrijn AF, Koppelman MH, Verhagen J, Brouwer MC, Schuitemaker H, Hack CE, Huisman HG. Novel strategy for the selection of human recombinant Fab fragments to membrane proteins from a phage-display library. J Immunol Methods 2002; 261(1-2):37-48. abstract |
| van Rij RP, Visser JA, van Praag RM, Rientsma R, Prins JM, Lange JM, Schuitemaker H. Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs. J Virol 2002; 76(6):3054-3058. abstract |
| de Pauw ES, Otto SA, Wijnen JT, Vossen JM, van Weel MH, Tanke HJ, Miedema F, Willemze R, Roelofs H, Fibbe WE. Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion. Br J Haematol 2002; 116(2):491-496. abstract |
| Goudsmit J, Weverling GJ, van der Hoek L, de Ronde A, Miedema F, Coutinho RA, Lange JM, Boerlijst MC. Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains. AIDS 2001; 15(17):2293-2301. abstract |
| van Rossum AM, Scherpbier HJ, van Lochem EG, Pakker NG, Slieker WA, Wolthers KC, Roos MT, Kuijpers JH, Hooijkaas H, Hartwig NG, Geelen SP, Wolfs TF, Lange JM, Miedema F, de Groot R. Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status. AIDS 2001; 15(17):2267-2275. abstract |
| Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, Martinez OP, Meyer L, Michael NL, Operskalski E, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Stewart GJ, Theodorou ID, Ullum H, Vicenzi E, Vlahov D, Wilkinson D, Workman C, Zagury JF, O'Brien TR. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3′A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med 2001; 135(9):782-795. abstract |
| Ghani AC, de Wolf F, Ferguson NM, Donnelly CA, Coutinho R, Miedema F, Goudsmit J, Anderson RM. Surrogate markers for disease progression in treated HIV infection. J Acquir Immune Defic Syndr 2001; 28(3):226-231. abstract |
| Hazenberg MD, Verschuren MC, Hamann D, Miedema F, van Dongen JJ. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med 2001; 79(11):631-640. abstract |
| Kostense S, van Baarle D, Hazenberg M, Miedema F. Het verloop van de infectie : nieuwe inzichten in de immunologie rond HIV. Pharm Weekbl 2001; 136(5):158-161. |
| Kwa D, Vingerhoed J, Boeser-Nunnink B, Broersen S, Schuitemaker H. Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)-T-cell subsets are determined only by coreceptor expression. J Virol 2001; 75(21):10455-10459. abstract |
| Notermans DW, de Jong JJ, Goudsmit J, Bakker MR, Roos MTL, Nijholt L, Cremers J, Hellings JA, Danner SA, de Ronde A. Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses. AIDS Res Hum Retroviruses 2001; 17(11):1003-1008. |
| Rentenaar RJ, Gamadia LE, van der Hoek N, van Diepen FNJ, Wertheim-van Dillen PME, Weel JFL, Surachno S, van Lier RAW, ten Berge IJM. CD8(POS) lymphocyte dynamics in primary CMV infection. Transpl Proc 2001; 33(1-2):1867-1869. |
| Rentenaar RJ, Vosters JLG, van Lier RAW, ten Berge IJM. Detection of allospecific T cells by intracellular cytokine staining and flowcytometry. Transpl Proc 2001; 33(1-2):426-427. |
| Vyakarnam A, Eyeson J, Teo I, Zuckerman M, Babaahmady K, Schuitemaker H, Shaunak S, Rostron T, Rowland-Jones S, Simmons G, Clapham P. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells. AIDS 2001; 15(13):1613-1626. abstract |
| Koning FA, Schols D, Schuitemaker H. No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1. J Virol 2001; 75(18):8848-8853. abstract |
| Kreisberg JF, Kwa D, Schramm B, Trautner V, Connor R, Schuitemaker H, Mullins JI, van 't Wout AB, Goldsmith MA. Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status. J Virol 2001; 75(18):8842-8847. abstract |
| Petit MD, Hovenkamp E, Hamann D, Roos MT, van der Velden U, Miedema F, Loos BG. Phenotypical and functional analysis of T cells in periodontitis. J Periodontal Res 2001; 36(4):214-220. abstract |
| Lindenburg CE, Langendam MW, Benthem BH, Miedema F, Coutinho RA. No evidence that vaccination with a polysaccharide pneumococcal vaccine protects drug users against all-cause pneumonia. AIDS 2001; 15(10):1315-1317. abstract |
| van Baarle D, Hovenkamp E, Callan MF, Wolthers KC, Kostense S, Tan LC, Niesters HG, Osterhaus AD, McMichael AJ, van Oers MH, Miedema F. Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma. Blood 2001; 98(1):146-155. abstract |
| Sanders EJ, Rinke de Wit TF, Fontanet AL, Goudsmit J, Miedema F, Coutinho RA. Ethiopia-Netherlands AIDS research project. Ned Tijdschr Geneeskd 2001; 145(26):1261-1265. abstract |
| van Praag RM, Prins JM, Roos MT, Schellekens PT, ten Berge IJ, Yong SL, Schuitemaker H, Eerenberg AJ, Jurriaans S, de Wolf F, Fox CH, Goudsmit J, Miedema F, Lange JM. OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion. J Clin Immunol 2001; 21(3):218-226. abstract |
| Messele T, Rinke de Wit TF, Brouwer M, Aklilu M, Birru T, Fontanet AL, Schuitemaker H, Hamann D. No difference in in vitro susceptibility to HIV type 1 between high-risk HIV-negative Ethiopian commercial sex workers and low-risk control subjects. AIDS Res Hum Retroviruses 2001; 17(5):433-441. abstract |
| Beaumont T, van Nuenen A, Broersen S, Blattner WA, Lukashov VV, Schuitemaker H. Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course. J Virol 2001; 75(5):2246-2252. abstract |
| Foudraine NA, Jurriaans S, Weverling GJ, Burger DM, Hoetelmans RM, Roos MT, Maas J, Miedema F, Reiss P, Portegies P, de Wolf F, Lange JM. Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial. Antivir Ther 2001; 6(1):55-62. abstract |
| Kostense S, Ogg GS, Manting EH, Gillespie G, Joling J, van den Berghe K, Veenhof EZ, van Baarle D, Jurriaans S, Klein MR, Miedema F. High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function. Eur J Immunol 2001; 31(3):677-686. abstract |
| Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers. Clin Immunol 2001; 98(2):212-219. abstract |
| Reijers MH, Weverling GJ, Jurriaans S, Roos MT, Wit FW, Weigel HM, ten Kate RW, Mulder JW, Richter C, Ter Hofstede HJ, Sprenger H, Hoetelmans RM, Schuitemaker H, Lange JM. The ADAM study continued: maintenance therapy after 50 weeks of induction therapy. AIDS 2001; 15(1):129-131. abstract |
| Beaumont T, Broersen S, van Nuenen AD, Huisman HG, de Roda Husman AM, Heeney JL, Schuitemaker H. Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short- term in vivo or in vitro passage through chimpanzees. J Virol 2000; 74(17):7699-7707. abstract |
| Cohen Stuart JW, Hazenberg MD, Hamann D, Otto SA, Borleffs JC, Miedema F, Boucher CA, de Boer RJ. The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation. J Acquir Immune Defic Syndr 2000; 25(3):203-211. abstract |
| Kootstra NA, Zwart BM, Schuitemaker H. Diminished human immunodeficiency virus type 1 reverse transcription and nuclear transport in primary macrophages arrested in early G(1) phase of the cell cycle. J Virol 2000; 74(4):1712-1717. abstract |
| Kostense S, Krop E, Blaak H, Schuitemaker H, Miedema F. Normalization of the CD4 T cell receptor repertoire after evolution of syncytium-inducing HIV-1 variants. AIDS 2000; 14(3):330-331. abstract |
| Maas JJ, Gange SJ, Schuitemaker H, Coutinho RA, van Leeuwen R, Margolick JB. Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study. AIDS 2000; 14(9):1155-1161. abstract |
| Putter H, Prins JM, Jurriaans S, Roos M, Ferguson NM, van Praag R, van der Hoek L, Schuitemaker H, Anderson RM, Goudsmit J, Lange JMA, de Wolf F. Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection. AIDS 2000; 14(18):2831-2839. abstract |
| Reijers MHE, Weigel HM, Hart AAM, ten Kate RW, Mulder JW, Reiss P, Schuitemaker H, Hoetelmans RMW, Weverling GJ, Lange JMA. Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study. AIDS 2000; 14(1):59-68. abstract |
| Hazenberg MD, Hamann D, Schuitemaker H, Miedema F. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol 2000; 1(4):285-289. abstract |
| van Rij RP, Blaak H, Visser JA, Brouwer M, Rientsma R, Broersen S, de Roda Husman AM, Schuitemaker H. Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1. J Clin Invest 2000; 106(8):1039-1052. abstract |
| van Rij RP, Blaak H, Visser JA, Brouwer M, Rientsma R, Broersen S, de Roda Husman AM, Schuitemaker H. Corrigenda : Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1. J Clin Invest 2000; 106(12):1569-1569. abstract |
| Hazenberg MD, Otto SA, Cohen Stuart JW, Verschuren MC, Borleffs JC, Boucher CA, Coutinho RA, Lange JM, Rinke de Wit TF, Tsegaye A, van Dongen JJ, Hamann D, de Boer RJ, Miedema F. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med 2000; 6(9):1036-1042. abstract |
| van Baarle D. Viro-Immunological studies on the role of Epstein-Barr virus in the development of AIDS-related non-Hodgkin′s Lymphoma. University of Amsterdam, Amsterdam, November 23, 2000; |
| Roos MT, van Lier RA, Hamann D, Knol GJ, Verhoofstad I, van Baarle D, Miedema F, Schellekens PT. Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans. J Infect Dis 2000; 182(2):451-458. abstract |
| Clark DR, Repping S, Pakker NG, Prins JM, Notermans DW, Wit FW, Reiss P, Danner SA, Coutinho RA, Lange JM, Miedema F. T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy. Blood 2000; 96(1):242-249. abstract |
| Messele T, Roos MT, Hamann D, Koot M, Fontanet AL, Miedema F, Schellekens PT, Rinke de Wit TF. Nonradioactive techniques for measurement of in vitro T-cell proliferation: alternatives to the [(3)H]thymidine incorporation assay. Clin Diagn Lab Immunol 2000; 7(4):687-692. abstract |
| van Baarle D, Hovenkamp E, Dukers NH, Renwick N, Kersten MJ, Goudsmit J, Coutinho RA, Miedema F, van Oers MH. High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission. J Infect Dis 2000; 181(6):2045-2049. abstract |
| Fleury S, Rizzardi GP, Chapuis A, Tambussi G, Knabenhans C, Simeoni E, Meuwly JY, Corpataux JM, Lazzarin A, Miedema F, Pantaleo G. Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy. Proc Natl Acad Sci U S A 2000; 97(10):5393-5398. abstract |
| Schuitemaker H, Miedema F. AIDS Pathogenesis. . . . 2000; |
| Scoggins RM, Taylor JR, Patrie J, van 't Wout AB, Schuitemaker H, Camerini D. Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice. J Virol 2000; 74(7):3205-3216. abstract |
| Blaak H, Ran LJ, Rientsma R, Schuitemaker H. Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production. Virology 2000; 267(2):237-246. abstract |
| Blaak H, van 't Wout AB, Brouwer M, Hooibrink B, Hovenkamp E, Schuitemaker H. In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. Proc Natl Acad Sci U S A 2000; 97(3):1269-1274. abstract |
| Lindenburg K, Langendam MW, Veenstra J, Miedema F, Coutinho R. Long-term effects of therapeutic vaccination with rgp 120. AIDS 2000; 14(2):203-204. abstract |
| Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, de Boer RJ, Miedema F, Hamann D. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 2000; 95(1):249-255. abstract |
| Tesselaar K. CD27/CD70 interactions in effector and memory cell formation. University of Amsterdam, Amsterdam, November 27, 2001; |